nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—CYP3A7—Tacrolimus—atopic dermatitis	0.0631	0.0791	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0631	0.0791	CbGbCtD
Erythromycin—SLCO1A2—Prednisolone—atopic dermatitis	0.049	0.0614	CbGbCtD
Erythromycin—CYP3A5—Tacrolimus—atopic dermatitis	0.0474	0.0593	CbGbCtD
Erythromycin—SLCO1A2—Hydrocortisone—atopic dermatitis	0.0464	0.0582	CbGbCtD
Erythromycin—SLCO1A2—Prednisone—atopic dermatitis	0.0463	0.058	CbGbCtD
Erythromycin—CYP2B6—Diphenhydramine—atopic dermatitis	0.044	0.0551	CbGbCtD
Erythromycin—CYP3A4—Pimecrolimus—atopic dermatitis	0.031	0.0389	CbGbCtD
Erythromycin—ABCB1—Tacrolimus—atopic dermatitis	0.0308	0.0386	CbGbCtD
Erythromycin—SLCO1A2—Dexamethasone—atopic dermatitis	0.0289	0.0362	CbGbCtD
Erythromycin—CYP1A2—Diphenhydramine—atopic dermatitis	0.0258	0.0323	CbGbCtD
Erythromycin—CYP3A7—Hydrocortisone—atopic dermatitis	0.0257	0.0322	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.0257	0.0322	CbGbCtD
Erythromycin—ABCB1—Loratadine—atopic dermatitis	0.0226	0.0283	CbGbCtD
Erythromycin—ABCB1—Methylprednisolone—atopic dermatitis	0.0206	0.0259	CbGbCtD
Erythromycin—CYP3A5—Hydrocortisone—atopic dermatitis	0.0193	0.0242	CbGbCtD
Erythromycin—CYP3A4—Tacrolimus—atopic dermatitis	0.0185	0.0231	CbGbCtD
Erythromycin—CYP3A7—Dexamethasone—atopic dermatitis	0.016	0.02	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.016	0.02	CbGbCtD
Erythromycin—CYP2B6—Dexamethasone—atopic dermatitis	0.0152	0.0191	CbGbCtD
Erythromycin—CYP3A4—Loratadine—atopic dermatitis	0.0135	0.0169	CbGbCtD
Erythromycin—ABCB1—Betamethasone—atopic dermatitis	0.0134	0.0168	CbGbCtD
Erythromycin—ABCB1—Prednisolone—atopic dermatitis	0.0132	0.0166	CbGbCtD
Erythromycin—ABCB1—Hydrocortisone—atopic dermatitis	0.0125	0.0157	CbGbCtD
Erythromycin—ABCB1—Prednisone—atopic dermatitis	0.0125	0.0157	CbGbCtD
Erythromycin—CYP3A4—Methylprednisolone—atopic dermatitis	0.0124	0.0155	CbGbCtD
Erythromycin—CYP3A5—Dexamethasone—atopic dermatitis	0.012	0.015	CbGbCtD
Erythromycin—CYP3A4—Triamcinolone—atopic dermatitis	0.00937	0.0117	CbGbCtD
Erythromycin—CYP3A4—Betamethasone—atopic dermatitis	0.00804	0.0101	CbGbCtD
Erythromycin—CYP3A4—Prednisolone—atopic dermatitis	0.00793	0.00994	CbGbCtD
Erythromycin—ABCB1—Dexamethasone—atopic dermatitis	0.0078	0.00978	CbGbCtD
Erythromycin—CYP3A4—Hydrocortisone—atopic dermatitis	0.00752	0.00942	CbGbCtD
Erythromycin—CYP3A4—Prednisone—atopic dermatitis	0.00749	0.00939	CbGbCtD
Erythromycin—CYP3A4—Dexamethasone—atopic dermatitis	0.00468	0.00586	CbGbCtD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.00158	0.0398	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.0014	0.0354	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00126	0.0318	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00106	0.0267	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00102	0.0256	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000942	0.0238	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000845	0.0213	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000828	0.0209	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—CCL22—atopic dermatitis	0.000805	0.0203	CbGpPWpGaD
Erythromycin—MLNR—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000747	0.0189	CbGpPWpGaD
Erythromycin—MLNR—G alpha (q) signalling events—NPS—atopic dermatitis	0.000747	0.0189	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000738	0.0186	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000738	0.0186	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000724	0.0183	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—CCL27—atopic dermatitis	0.000718	0.0181	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000681	0.0172	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000668	0.0169	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000668	0.0169	CbGpPWpGaD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000648	0.0164	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—CCL17—atopic dermatitis	0.000644	0.0162	CbGpPWpGaD
Erythromycin—Pancreatitis—Tacrolimus—atopic dermatitis	0.000627	0.00386	CcSEcCtD
Erythromycin—Skin exfoliation—Hydrocortisone—atopic dermatitis	0.000607	0.00374	CcSEcCtD
Erythromycin—Decreased appetite—Diphenhydramine—atopic dermatitis	0.000601	0.0037	CcSEcCtD
Erythromycin—Decreased appetite—Dimenhydrinate—atopic dermatitis	0.000601	0.0037	CcSEcCtD
Erythromycin—Rash—Desonide—atopic dermatitis	0.000596	0.00367	CcSEcCtD
Erythromycin—Erythema—Fluocinolone Acetonide—atopic dermatitis	0.000586	0.00361	CcSEcCtD
Erythromycin—MLNR—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000585	0.0148	CbGpPWpGaD
Erythromycin—Palpitations—Loratadine—atopic dermatitis	0.000576	0.00355	CcSEcCtD
Erythromycin—Dysgeusia—Fluocinolone Acetonide—atopic dermatitis	0.000574	0.00353	CcSEcCtD
Erythromycin—Pain—Pimecrolimus—atopic dermatitis	0.000571	0.00352	CcSEcCtD
Erythromycin—Skin exfoliation—Triamcinolone—atopic dermatitis	0.000571	0.00352	CcSEcCtD
Erythromycin—Skin exfoliation—Methylprednisolone—atopic dermatitis	0.00057	0.00351	CcSEcCtD
Erythromycin—Feeling abnormal—Diphenhydramine—atopic dermatitis	0.000569	0.00351	CcSEcCtD
Erythromycin—Feeling abnormal—Dimenhydrinate—atopic dermatitis	0.000569	0.00351	CcSEcCtD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000567	0.0143	CbGpPWpGaD
Erythromycin—Stevens-Johnson syndrome—Tacrolimus—atopic dermatitis	0.000565	0.00348	CcSEcCtD
Erythromycin—Hypersensitivity—Fluocinonide—atopic dermatitis	0.000565	0.00348	CcSEcCtD
Erythromycin—Jaundice—Tacrolimus—atopic dermatitis	0.000556	0.00342	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000555	0.014	CbGpPWpGaD
Erythromycin—Chest pain—Loratadine—atopic dermatitis	0.000555	0.00342	CcSEcCtD
Erythromycin—Urticaria—Diphenhydramine—atopic dermatitis	0.000549	0.00338	CcSEcCtD
Erythromycin—Urticaria—Dimenhydrinate—atopic dermatitis	0.000549	0.00338	CcSEcCtD
Erythromycin—Discomfort—Loratadine—atopic dermatitis	0.000548	0.00338	CcSEcCtD
Erythromycin—Gastrointestinal pain—Pimecrolimus—atopic dermatitis	0.000546	0.00336	CcSEcCtD
Erythromycin—Pruritus—Fluocinonide—atopic dermatitis	0.000542	0.00334	CcSEcCtD
Erythromycin—Anaphylactic shock—Loratadine—atopic dermatitis	0.000532	0.00328	CcSEcCtD
Erythromycin—Urticaria—Pimecrolimus—atopic dermatitis	0.000531	0.00327	CcSEcCtD
Erythromycin—Abdominal pain—Pimecrolimus—atopic dermatitis	0.000528	0.00325	CcSEcCtD
Erythromycin—Vertigo—Fluocinolone Acetonide—atopic dermatitis	0.000527	0.00324	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—CCL11—atopic dermatitis	0.000519	0.0131	CbGpPWpGaD
Erythromycin—Skin exfoliation—Betamethasone—atopic dermatitis	0.000518	0.00319	CcSEcCtD
Erythromycin—Skin exfoliation—Dexamethasone—atopic dermatitis	0.000518	0.00319	CcSEcCtD
Erythromycin—Injury—Prednisolone—atopic dermatitis	0.000514	0.00316	CcSEcCtD
Erythromycin—Hepatitis—Tacrolimus—atopic dermatitis	0.000512	0.00315	CcSEcCtD
Erythromycin—Hallucination—Tacrolimus—atopic dermatitis	0.000509	0.00313	CcSEcCtD
Erythromycin—Dizziness—Fluocinonide—atopic dermatitis	0.000507	0.00312	CcSEcCtD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000504	0.0127	CbGpPWpGaD
Erythromycin—Injury—Hydrocortisone—atopic dermatitis	0.000502	0.00309	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000495	0.0125	CbGpPWpGaD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000495	0.0125	CbGpPWpGaD
Erythromycin—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.000492	0.00303	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000485	0.0122	CbGpPWpGaD
Erythromycin—Erythema multiforme—Tacrolimus—atopic dermatitis	0.000484	0.00298	CcSEcCtD
Erythromycin—Rash—Fluocinonide—atopic dermatitis	0.000483	0.00298	CcSEcCtD
Erythromycin—Tinnitus—Tacrolimus—atopic dermatitis	0.000477	0.00294	CcSEcCtD
Erythromycin—Chest pain—Mometasone—atopic dermatitis	0.000476	0.00293	CcSEcCtD
Erythromycin—Diarrhoea—Diphenhydramine—atopic dermatitis	0.000473	0.00291	CcSEcCtD
Erythromycin—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.000473	0.00291	CcSEcCtD
Erythromycin—Pruritus—Pimecrolimus—atopic dermatitis	0.000473	0.00291	CcSEcCtD
Erythromycin—Injury—Triamcinolone—atopic dermatitis	0.000473	0.00291	CcSEcCtD
Erythromycin—Injury—Methylprednisolone—atopic dermatitis	0.000472	0.0029	CcSEcCtD
Erythromycin—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000457	0.00282	CcSEcCtD
Erythromycin—Arrhythmia—Tacrolimus—atopic dermatitis	0.000457	0.00281	CcSEcCtD
Erythromycin—Dizziness—Diphenhydramine—atopic dermatitis	0.000457	0.00281	CcSEcCtD
Erythromycin—Dizziness—Dimenhydrinate—atopic dermatitis	0.000457	0.00281	CcSEcCtD
Erythromycin—Anaphylactic shock—Mometasone—atopic dermatitis	0.000457	0.00281	CcSEcCtD
Erythromycin—Pain—Loratadine—atopic dermatitis	0.000455	0.0028	CcSEcCtD
Erythromycin—MLNR—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000454	0.0114	CbGpPWpGaD
Erythromycin—Skin exfoliation—Prednisone—atopic dermatitis	0.000451	0.00278	CcSEcCtD
Erythromycin—Erythema—Tacrolimus—atopic dermatitis	0.000445	0.00274	CcSEcCtD
Erythromycin—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.000441	0.0111	CbGpPWpGaD
Erythromycin—Irritability—Hydrocortisone—atopic dermatitis	0.00044	0.00271	CcSEcCtD
Erythromycin—Vomiting—Diphenhydramine—atopic dermatitis	0.000439	0.00271	CcSEcCtD
Erythromycin—Vomiting—Dimenhydrinate—atopic dermatitis	0.000439	0.00271	CcSEcCtD
Erythromycin—Feeling abnormal—Loratadine—atopic dermatitis	0.000439	0.0027	CcSEcCtD
Erythromycin—Dysgeusia—Tacrolimus—atopic dermatitis	0.000436	0.00269	CcSEcCtD
Erythromycin—Rash—Dimenhydrinate—atopic dermatitis	0.000436	0.00268	CcSEcCtD
Erythromycin—Rash—Diphenhydramine—atopic dermatitis	0.000436	0.00268	CcSEcCtD
Erythromycin—Anorexia—Mometasone—atopic dermatitis	0.000435	0.00268	CcSEcCtD
Erythromycin—Gastrointestinal pain—Loratadine—atopic dermatitis	0.000435	0.00268	CcSEcCtD
Erythromycin—Injury—Betamethasone—atopic dermatitis	0.000429	0.00264	CcSEcCtD
Erythromycin—Injury—Dexamethasone—atopic dermatitis	0.000429	0.00264	CcSEcCtD
Erythromycin—Vomiting—Pimecrolimus—atopic dermatitis	0.000425	0.00262	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—CCR3—atopic dermatitis	0.000423	0.0107	CbGpPWpGaD
Erythromycin—Rash—Pimecrolimus—atopic dermatitis	0.000421	0.00259	CcSEcCtD
Erythromycin—Abdominal pain—Loratadine—atopic dermatitis	0.000421	0.00259	CcSEcCtD
Erythromycin—Irritability—Methylprednisolone—atopic dermatitis	0.000414	0.00255	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CCL22—atopic dermatitis	0.000413	0.0104	CbGpPWpGaD
Erythromycin—Nausea—Diphenhydramine—atopic dermatitis	0.00041	0.00253	CcSEcCtD
Erythromycin—Nausea—Dimenhydrinate—atopic dermatitis	0.00041	0.00253	CcSEcCtD
Erythromycin—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000409	0.00252	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—CCL27—atopic dermatitis	0.000405	0.0102	CbGpPWpGaD
Erythromycin—Pancreatitis—Prednisolone—atopic dermatitis	0.0004	0.00246	CcSEcCtD
Erythromycin—Vertigo—Tacrolimus—atopic dermatitis	0.0004	0.00246	CcSEcCtD
Erythromycin—Decreased appetite—Mometasone—atopic dermatitis	0.000397	0.00244	CcSEcCtD
Erythromycin—Nausea—Pimecrolimus—atopic dermatitis	0.000397	0.00244	CcSEcCtD
Erythromycin—Palpitations—Tacrolimus—atopic dermatitis	0.000394	0.00242	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000392	0.0099	CbGpPWpGaD
Erythromycin—Pancreatitis—Hydrocortisone—atopic dermatitis	0.000391	0.00241	CcSEcCtD
Erythromycin—Pain—Mometasone—atopic dermatitis	0.000391	0.0024	CcSEcCtD
Erythromycin—Convulsion—Tacrolimus—atopic dermatitis	0.000386	0.00238	CcSEcCtD
Erythromycin—Chest pain—Tacrolimus—atopic dermatitis	0.000379	0.00233	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—NPS—atopic dermatitis	0.000377	0.00951	CbGpPWpGaD
Erythromycin—MLNR—GPCR ligand binding—TAC1—atopic dermatitis	0.000377	0.00951	CbGpPWpGaD
Erythromycin—Irritability—Betamethasone—atopic dermatitis	0.000376	0.00232	CcSEcCtD
Erythromycin—Irritability—Dexamethasone—atopic dermatitis	0.000376	0.00232	CcSEcCtD
Erythromycin—Discomfort—Tacrolimus—atopic dermatitis	0.000375	0.00231	CcSEcCtD
Erythromycin—Injury—Prednisone—atopic dermatitis	0.000373	0.0023	CcSEcCtD
Erythromycin—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000373	0.0023	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—CXCR3—atopic dermatitis	0.00037	0.00932	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CCL27—atopic dermatitis	0.000368	0.00929	CbGpPWpGaD
Erythromycin—Pancreatitis—Triamcinolone—atopic dermatitis	0.000368	0.00227	CcSEcCtD
Erythromycin—Pancreatitis—Methylprednisolone—atopic dermatitis	0.000367	0.00226	CcSEcCtD
Erythromycin—Confusional state—Tacrolimus—atopic dermatitis	0.000367	0.00226	CcSEcCtD
Erythromycin—Diarrhoea—Loratadine—atopic dermatitis	0.000364	0.00224	CcSEcCtD
Erythromycin—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.000363	0.00224	CcSEcCtD
Erythromycin—Abdominal pain—Mometasone—atopic dermatitis	0.000361	0.00222	CcSEcCtD
Erythromycin—MLNR—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000355	0.00896	CbGpPWpGaD
Erythromycin—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000352	0.00217	CcSEcCtD
Erythromycin—Dizziness—Loratadine—atopic dermatitis	0.000352	0.00217	CcSEcCtD
Erythromycin—Anorexia—Tacrolimus—atopic dermatitis	0.000346	0.00213	CcSEcCtD
Erythromycin—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000338	0.00208	CcSEcCtD
Erythromycin—Vomiting—Loratadine—atopic dermatitis	0.000338	0.00208	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000338	0.00852	CbGpPWpGaD
Erythromycin—Rash—Loratadine—atopic dermatitis	0.000336	0.00207	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CCL17—atopic dermatitis	0.00033	0.00833	CbGpPWpGaD
Erythromycin—Irritability—Prednisone—atopic dermatitis	0.000328	0.00202	CcSEcCtD
Erythromycin—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000327	0.00202	CcSEcCtD
Erythromycin—Pruritus—Mometasone—atopic dermatitis	0.000323	0.00199	CcSEcCtD
Erythromycin—Hallucination—Hydrocortisone—atopic dermatitis	0.000318	0.00196	CcSEcCtD
Erythromycin—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000316	0.00195	CcSEcCtD
Erythromycin—Nausea—Loratadine—atopic dermatitis	0.000316	0.00195	CcSEcCtD
Erythromycin—Decreased appetite—Tacrolimus—atopic dermatitis	0.000316	0.00195	CcSEcCtD
Erythromycin—Diarrhoea—Mometasone—atopic dermatitis	0.000312	0.00192	CcSEcCtD
Erythromycin—Pain—Tacrolimus—atopic dermatitis	0.000311	0.00191	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000304	0.00768	CbGpPWpGaD
Erythromycin—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000304	0.00187	CcSEcCtD
Erythromycin—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000302	0.00186	CcSEcCtD
Erythromycin—Feeling abnormal—Tacrolimus—atopic dermatitis	0.0003	0.00184	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—CXCL10—atopic dermatitis	0.000299	0.00754	CbGpPWpGaD
Erythromycin—Hallucination—Methylprednisolone—atopic dermatitis	0.000298	0.00184	CcSEcCtD
Erythromycin—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000297	0.00183	CcSEcCtD
Erythromycin—Arrhythmia—Prednisolone—atopic dermatitis	0.000292	0.0018	CcSEcCtD
Erythromycin—Pancreatitis—Prednisone—atopic dermatitis	0.000291	0.00179	CcSEcCtD
Erythromycin—Vomiting—Mometasone—atopic dermatitis	0.00029	0.00179	CcSEcCtD
Erythromycin—Urticaria—Tacrolimus—atopic dermatitis	0.000289	0.00178	CcSEcCtD
Erythromycin—Rash—Mometasone—atopic dermatitis	0.000288	0.00177	CcSEcCtD
Erythromycin—Abdominal pain—Tacrolimus—atopic dermatitis	0.000287	0.00177	CcSEcCtD
Erythromycin—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000285	0.00176	CcSEcCtD
Erythromycin—Erythema—Prednisolone—atopic dermatitis	0.000284	0.00175	CcSEcCtD
Erythromycin—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000284	0.00175	CcSEcCtD
Erythromycin—Erythema—Hydrocortisone—atopic dermatitis	0.000278	0.00171	CcSEcCtD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000278	0.007	CbGpPWpGaD
Erythromycin—MLNR—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000274	0.00692	CbGpPWpGaD
Erythromycin—CYP1A2—Estrogen Receptor Pathway—PPARA—atopic dermatitis	0.000272	0.00686	CbGpPWpGaD
Erythromycin—Hallucination—Dexamethasone—atopic dermatitis	0.000271	0.00167	CcSEcCtD
Erythromycin—Hallucination—Betamethasone—atopic dermatitis	0.000271	0.00167	CcSEcCtD
Erythromycin—Nausea—Mometasone—atopic dermatitis	0.000271	0.00167	CcSEcCtD
Erythromycin—Arrhythmia—Triamcinolone—atopic dermatitis	0.000268	0.00165	CcSEcCtD
Erythromycin—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000268	0.00165	CcSEcCtD
Erythromycin—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000268	0.00165	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CCL11—atopic dermatitis	0.000266	0.00672	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—FCER2—atopic dermatitis	0.000263	0.00662	CbGpPWpGaD
Erythromycin—Erythema—Triamcinolone—atopic dermatitis	0.000262	0.00161	CcSEcCtD
Erythromycin—Erythema—Methylprednisolone—atopic dermatitis	0.000261	0.00161	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—CCL5—atopic dermatitis	0.000257	0.00649	CbGpPWpGaD
Erythromycin—Pruritus—Tacrolimus—atopic dermatitis	0.000257	0.00158	CcSEcCtD
Erythromycin—Dysgeusia—Triamcinolone—atopic dermatitis	0.000256	0.00158	CcSEcCtD
Erythromycin—Vertigo—Prednisolone—atopic dermatitis	0.000256	0.00157	CcSEcCtD
Erythromycin—Vertigo—Hydrocortisone—atopic dermatitis	0.00025	0.00154	CcSEcCtD
Erythromycin—Diarrhoea—Tacrolimus—atopic dermatitis	0.000249	0.00153	CcSEcCtD
Erythromycin—Convulsion—Prednisolone—atopic dermatitis	0.000246	0.00152	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—CCL22—atopic dermatitis	0.000244	0.00616	CbGpPWpGaD
Erythromycin—Arrhythmia—Dexamethasone—atopic dermatitis	0.000244	0.0015	CcSEcCtD
Erythromycin—Arrhythmia—Betamethasone—atopic dermatitis	0.000244	0.0015	CcSEcCtD
Erythromycin—Convulsion—Hydrocortisone—atopic dermatitis	0.000241	0.00148	CcSEcCtD
Erythromycin—Dizziness—Tacrolimus—atopic dermatitis	0.00024	0.00148	CcSEcCtD
Erythromycin—Discomfort—Prednisolone—atopic dermatitis	0.000239	0.00147	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—CCR3—atopic dermatitis	0.000239	0.00603	CbGpPWpGaD
Erythromycin—Erythema—Betamethasone—atopic dermatitis	0.000237	0.00146	CcSEcCtD
Erythromycin—Erythema—Dexamethasone—atopic dermatitis	0.000237	0.00146	CcSEcCtD
Erythromycin—Hallucination—Prednisone—atopic dermatitis	0.000236	0.00145	CcSEcCtD
Erythromycin—Vertigo—Triamcinolone—atopic dermatitis	0.000235	0.00145	CcSEcCtD
Erythromycin—Vertigo—Methylprednisolone—atopic dermatitis	0.000235	0.00144	CcSEcCtD
Erythromycin—Discomfort—Hydrocortisone—atopic dermatitis	0.000234	0.00144	CcSEcCtD
Erythromycin—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000232	0.00143	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—CCR5—atopic dermatitis	0.000232	0.00584	CbGpPWpGaD
Erythromycin—Vomiting—Tacrolimus—atopic dermatitis	0.000231	0.00142	CcSEcCtD
Erythromycin—Rash—Tacrolimus—atopic dermatitis	0.000229	0.00141	CcSEcCtD
Erythromycin—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000227	0.0014	CcSEcCtD
Erythromycin—Convulsion—Triamcinolone—atopic dermatitis	0.000227	0.0014	CcSEcCtD
Erythromycin—Convulsion—Methylprednisolone—atopic dermatitis	0.000226	0.00139	CcSEcCtD
Erythromycin—Discomfort—Triamcinolone—atopic dermatitis	0.00022	0.00136	CcSEcCtD
Erythromycin—Discomfort—Methylprednisolone—atopic dermatitis	0.00022	0.00135	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—CCL27—atopic dermatitis	0.000218	0.00549	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CCR3—atopic dermatitis	0.000217	0.00547	CbGpPWpGaD
Erythromycin—Anorexia—Hydrocortisone—atopic dermatitis	0.000216	0.00133	CcSEcCtD
Erythromycin—Nausea—Tacrolimus—atopic dermatitis	0.000216	0.00133	CcSEcCtD
Erythromycin—Confusional state—Methylprednisolone—atopic dermatitis	0.000215	0.00132	CcSEcCtD
Erythromycin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000214	0.0054	CbGpPWpGaD
Erythromycin—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000214	0.00131	CcSEcCtD
Erythromycin—Vertigo—Betamethasone—atopic dermatitis	0.000213	0.00131	CcSEcCtD
Erythromycin—Vertigo—Dexamethasone—atopic dermatitis	0.000213	0.00131	CcSEcCtD
Erythromycin—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000213	0.00131	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—TAC1—atopic dermatitis	0.000213	0.00537	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—NPS—atopic dermatitis	0.000213	0.00537	CbGpPWpGaD
Erythromycin—Arrhythmia—Prednisone—atopic dermatitis	0.000212	0.00131	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000209	0.00527	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000207	0.00522	CbGpPWpGaD
Erythromycin—Erythema—Prednisone—atopic dermatitis	0.000207	0.00127	CcSEcCtD
Erythromycin—Convulsion—Betamethasone—atopic dermatitis	0.000206	0.00127	CcSEcCtD
Erythromycin—Convulsion—Dexamethasone—atopic dermatitis	0.000206	0.00127	CcSEcCtD
Erythromycin—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.0002	0.00506	CbGpPWpGaD
Erythromycin—Discomfort—Betamethasone—atopic dermatitis	0.0002	0.00123	CcSEcCtD
Erythromycin—Discomfort—Dexamethasone—atopic dermatitis	0.0002	0.00123	CcSEcCtD
Erythromycin—Pain—Prednisolone—atopic dermatitis	0.000199	0.00122	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—IL5—atopic dermatitis	0.000198	0.005	CbGpPWpGaD
Erythromycin—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000197	0.00121	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—CCL17—atopic dermatitis	0.000195	0.00492	CbGpPWpGaD
Erythromycin—Pain—Hydrocortisone—atopic dermatitis	0.000194	0.00119	CcSEcCtD
Erythromycin—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000194	0.00119	CcSEcCtD
Erythromycin—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000194	0.00119	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—TAC1—atopic dermatitis	0.000193	0.00488	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—NPS—atopic dermatitis	0.000193	0.00488	CbGpPWpGaD
Erythromycin—Feeling abnormal—Prednisolone—atopic dermatitis	0.000191	0.00118	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CXCR3—atopic dermatitis	0.00019	0.00479	CbGpPWpGaD
Erythromycin—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000187	0.00115	CcSEcCtD
Erythromycin—ABCC1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.000186	0.0047	CbGpPWpGaD
Erythromycin—Vertigo—Prednisone—atopic dermatitis	0.000186	0.00114	CcSEcCtD
Erythromycin—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000185	0.00114	CcSEcCtD
Erythromycin—Anorexia—Dexamethasone—atopic dermatitis	0.000185	0.00114	CcSEcCtD
Erythromycin—Anorexia—Betamethasone—atopic dermatitis	0.000185	0.00114	CcSEcCtD
Erythromycin—Urticaria—Prednisolone—atopic dermatitis	0.000184	0.00114	CcSEcCtD
Erythromycin—MLNR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000184	0.00464	CbGpPWpGaD
Erythromycin—Pain—Triamcinolone—atopic dermatitis	0.000183	0.00112	CcSEcCtD
Erythromycin—Urticaria—Hydrocortisone—atopic dermatitis	0.00018	0.00111	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—IL5—atopic dermatitis	0.00018	0.00454	CbGpPWpGaD
Erythromycin—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000179	0.0011	CcSEcCtD
Erythromycin—Convulsion—Prednisone—atopic dermatitis	0.000179	0.0011	CcSEcCtD
Erythromycin—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000176	0.00108	CcSEcCtD
Erythromycin—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000176	0.00108	CcSEcCtD
Erythromycin—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000174	0.00107	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—KIF3A—atopic dermatitis	0.000174	0.00439	CbGpPWpGaD
Erythromycin—Discomfort—Prednisone—atopic dermatitis	0.000174	0.00107	CcSEcCtD
Erythromycin—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	0.000173	0.00437	CbGpPWpGaD
Erythromycin—Hypersensitivity—Prednisolone—atopic dermatitis	0.000171	0.00105	CcSEcCtD
Erythromycin—Urticaria—Triamcinolone—atopic dermatitis	0.00017	0.00104	CcSEcCtD
Erythromycin—Urticaria—Methylprednisolone—atopic dermatitis	0.000169	0.00104	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000169	0.00426	CbGpPWpGaD
Erythromycin—Anaphylactic shock—Prednisone—atopic dermatitis	0.000169	0.00104	CcSEcCtD
Erythromycin—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000168	0.00104	CcSEcCtD
Erythromycin—Decreased appetite—Dexamethasone—atopic dermatitis	0.000168	0.00104	CcSEcCtD
Erythromycin—Decreased appetite—Betamethasone—atopic dermatitis	0.000168	0.00104	CcSEcCtD
Erythromycin—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000167	0.00103	CcSEcCtD
Erythromycin—Pain—Betamethasone—atopic dermatitis	0.000166	0.00102	CcSEcCtD
Erythromycin—Pain—Dexamethasone—atopic dermatitis	0.000166	0.00102	CcSEcCtD
Erythromycin—Anorexia—Prednisone—atopic dermatitis	0.000161	0.00099	CcSEcCtD
Erythromycin—Pruritus—Hydrocortisone—atopic dermatitis	0.00016	0.000988	CcSEcCtD
Erythromycin—Feeling abnormal—Dexamethasone—atopic dermatitis	0.00016	0.000983	CcSEcCtD
Erythromycin—Feeling abnormal—Betamethasone—atopic dermatitis	0.00016	0.000983	CcSEcCtD
Erythromycin—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000158	0.000976	CcSEcCtD
Erythromycin—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000158	0.000976	CcSEcCtD
Erythromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000158	0.00398	CbGpPWpGaD
Erythromycin—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000157	0.000969	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—CMA1—atopic dermatitis	0.000157	0.00397	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCL11—atopic dermatitis	0.000157	0.00397	CbGpPWpGaD
Erythromycin—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000157	0.000967	CcSEcCtD
Erythromycin—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000155	0.000955	CcSEcCtD
Erythromycin—Urticaria—Betamethasone—atopic dermatitis	0.000154	0.000948	CcSEcCtD
Erythromycin—Urticaria—Dexamethasone—atopic dermatitis	0.000154	0.000948	CcSEcCtD
Erythromycin—Dizziness—Prednisolone—atopic dermatitis	0.000154	0.000945	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CXCL10—atopic dermatitis	0.000153	0.00387	CbGpPWpGaD
Erythromycin—Abdominal pain—Dexamethasone—atopic dermatitis	0.000153	0.000943	CcSEcCtD
Erythromycin—Abdominal pain—Betamethasone—atopic dermatitis	0.000153	0.000943	CcSEcCtD
Erythromycin—Pruritus—Triamcinolone—atopic dermatitis	0.000151	0.00093	CcSEcCtD
Erythromycin—Pruritus—Methylprednisolone—atopic dermatitis	0.000151	0.000928	CcSEcCtD
Erythromycin—Dizziness—Hydrocortisone—atopic dermatitis	0.00015	0.000923	CcSEcCtD
Erythromycin—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.00015	0.00377	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL13—atopic dermatitis	0.000148	0.00374	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—STAT6—atopic dermatitis	0.000148	0.00373	CbGpPWpGaD
Erythromycin—Decreased appetite—Prednisone—atopic dermatitis	0.000147	0.000903	CcSEcCtD
Erythromycin—Rash—Prednisolone—atopic dermatitis	0.000146	0.000901	CcSEcCtD
Erythromycin—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000146	0.000898	CcSEcCtD
Erythromycin—MLNR—GPCR downstream signaling—CCL5—atopic dermatitis	0.000145	0.00367	CbGpPWpGaD
Erythromycin—Vomiting—Hydrocortisone—atopic dermatitis	0.000144	0.000888	CcSEcCtD
Erythromycin—Rash—Hydrocortisone—atopic dermatitis	0.000143	0.00088	CcSEcCtD
Erythromycin—Dizziness—Triamcinolone—atopic dermatitis	0.000141	0.000869	CcSEcCtD
Erythromycin—Dizziness—Methylprednisolone—atopic dermatitis	0.000141	0.000867	CcSEcCtD
Erythromycin—MLNR—GPCR ligand binding—CXCL8—atopic dermatitis	0.00014	0.00353	CbGpPWpGaD
Erythromycin—MLNR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.00014	0.00352	CbGpPWpGaD
Erythromycin—Feeling abnormal—Prednisone—atopic dermatitis	0.000139	0.000856	CcSEcCtD
Erythromycin—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000138	0.00085	CcSEcCtD
Erythromycin—Nausea—Prednisolone—atopic dermatitis	0.000138	0.000849	CcSEcCtD
Erythromycin—Pruritus—Dexamethasone—atopic dermatitis	0.000137	0.000844	CcSEcCtD
Erythromycin—Pruritus—Betamethasone—atopic dermatitis	0.000137	0.000844	CcSEcCtD
Erythromycin—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	0.000137	0.00344	CbGpPWpGaD
Erythromycin—Vomiting—Triamcinolone—atopic dermatitis	0.000136	0.000836	CcSEcCtD
Erythromycin—Vomiting—Methylprednisolone—atopic dermatitis	0.000135	0.000834	CcSEcCtD
Erythromycin—Nausea—Hydrocortisone—atopic dermatitis	0.000135	0.000829	CcSEcCtD
Erythromycin—Rash—Triamcinolone—atopic dermatitis	0.000135	0.000829	CcSEcCtD
Erythromycin—Rash—Methylprednisolone—atopic dermatitis	0.000134	0.000827	CcSEcCtD
Erythromycin—Urticaria—Prednisone—atopic dermatitis	0.000134	0.000825	CcSEcCtD
Erythromycin—Abdominal pain—Prednisone—atopic dermatitis	0.000133	0.000821	CcSEcCtD
Erythromycin—Diarrhoea—Betamethasone—atopic dermatitis	0.000133	0.000816	CcSEcCtD
Erythromycin—Diarrhoea—Dexamethasone—atopic dermatitis	0.000133	0.000816	CcSEcCtD
Erythromycin—MLNR—Signaling by GPCR—CCL5—atopic dermatitis	0.000132	0.00333	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—CCR5—atopic dermatitis	0.000131	0.0033	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCR3—atopic dermatitis	0.000128	0.00323	CbGpPWpGaD
Erythromycin—Dizziness—Betamethasone—atopic dermatitis	0.000128	0.000789	CcSEcCtD
Erythromycin—Dizziness—Dexamethasone—atopic dermatitis	0.000128	0.000789	CcSEcCtD
Erythromycin—ABCB1—Allograft Rejection—IL5—atopic dermatitis	0.000127	0.0032	CbGpPWpGaD
Erythromycin—Nausea—Triamcinolone—atopic dermatitis	0.000127	0.000781	CcSEcCtD
Erythromycin—Nausea—Methylprednisolone—atopic dermatitis	0.000127	0.000779	CcSEcCtD
Erythromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000126	0.00318	CbGpPWpGaD
Erythromycin—Hypersensitivity—Prednisone—atopic dermatitis	0.000124	0.000765	CcSEcCtD
Erythromycin—Vomiting—Betamethasone—atopic dermatitis	0.000123	0.000758	CcSEcCtD
Erythromycin—Vomiting—Dexamethasone—atopic dermatitis	0.000123	0.000758	CcSEcCtD
Erythromycin—Rash—Betamethasone—atopic dermatitis	0.000122	0.000752	CcSEcCtD
Erythromycin—Rash—Dexamethasone—atopic dermatitis	0.000122	0.000752	CcSEcCtD
Erythromycin—Pruritus—Prednisone—atopic dermatitis	0.000119	0.000735	CcSEcCtD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000119	0.00301	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CCR5—atopic dermatitis	0.000119	0.003	CbGpPWpGaD
Erythromycin—Diarrhoea—Prednisone—atopic dermatitis	0.000115	0.000711	CcSEcCtD
Erythromycin—Nausea—Dexamethasone—atopic dermatitis	0.000115	0.000709	CcSEcCtD
Erythromycin—Nausea—Betamethasone—atopic dermatitis	0.000115	0.000709	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—NPS—atopic dermatitis	0.000114	0.00288	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TAC1—atopic dermatitis	0.000114	0.00288	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CXCR3—atopic dermatitis	0.000112	0.00283	CbGpPWpGaD
Erythromycin—Dizziness—Prednisone—atopic dermatitis	0.000112	0.000687	CcSEcCtD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000107	0.00271	CbGpPWpGaD
Erythromycin—Vomiting—Prednisone—atopic dermatitis	0.000107	0.000661	CcSEcCtD
Erythromycin—Rash—Prednisone—atopic dermatitis	0.000106	0.000655	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—IL5—atopic dermatitis	0.000106	0.00268	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000102	0.00257	CbGpPWpGaD
Erythromycin—Nausea—Prednisone—atopic dermatitis	0.0001	0.000617	CcSEcCtD
Erythromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	9.73e-05	0.00245	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL10—atopic dermatitis	9.28e-05	0.00234	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CXCL10—atopic dermatitis	9.06e-05	0.00228	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL4—atopic dermatitis	9.03e-05	0.00228	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	8.87e-05	0.00224	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—CXCL8—atopic dermatitis	7.92e-05	0.002	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCL5—atopic dermatitis	7.8e-05	0.00197	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	7.6e-05	0.00192	CbGpPWpGaD
Erythromycin—MLNR—GPCR downstream signaling—IL2—atopic dermatitis	7.57e-05	0.00191	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—NGF—atopic dermatitis	7.22e-05	0.00182	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—CXCL8—atopic dermatitis	7.19e-05	0.00181	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CCR5—atopic dermatitis	7.02e-05	0.00177	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—IL2—atopic dermatitis	6.87e-05	0.00173	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	6.84e-05	0.00173	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	6.71e-05	0.00169	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	6.42e-05	0.00162	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	5.99e-05	0.00151	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	5.97e-05	0.00151	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—NFKBIA—atopic dermatitis	5.95e-05	0.0015	CbGpPWpGaD
Erythromycin—ABCC1—Disease—GLB1—atopic dermatitis	5.71e-05	0.00144	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	5.46e-05	0.00138	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GLB1—atopic dermatitis	5.31e-05	0.00134	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ADSL—atopic dermatitis	5.1e-05	0.00129	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	5.07e-05	0.00128	CbGpPWpGaD
Erythromycin—SLC22A7—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4.93e-05	0.00124	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	4.87e-05	0.00123	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—IL2—atopic dermatitis	4.85e-05	0.00122	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	4.8e-05	0.00121	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GLB1—atopic dermatitis	4.78e-05	0.00121	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ADSL—atopic dermatitis	4.59e-05	0.00116	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	4.35e-05	0.0011	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	4.35e-05	0.0011	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—CXCL8—atopic dermatitis	4.25e-05	0.00107	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GLB1—atopic dermatitis	4.17e-05	0.00105	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.08e-05	0.00103	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—IL2—atopic dermatitis	4.06e-05	0.00102	CbGpPWpGaD
Erythromycin—MLNR—Signaling by GPCR—IL6—atopic dermatitis	4.04e-05	0.00102	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ADSL—atopic dermatitis	4e-05	0.00101	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.87e-05	0.000977	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SLC11A1—atopic dermatitis	3.83e-05	0.000965	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—MAPK8—atopic dermatitis	3.74e-05	0.000942	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.68e-05	0.000929	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—TNF—atopic dermatitis	3.53e-05	0.000891	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.51e-05	0.000886	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.49e-05	0.000879	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.31e-05	0.000836	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.25e-05	0.000821	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.17e-05	0.000799	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GLB1—atopic dermatitis	3.08e-05	0.000778	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GLB1—atopic dermatitis	3.02e-05	0.000761	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ADSL—atopic dermatitis	2.96e-05	0.000746	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ADSL—atopic dermatitis	2.89e-05	0.000729	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—IL6—atopic dermatitis	2.39e-05	0.000602	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GLB1—atopic dermatitis	2.28e-05	0.000574	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.2e-05	0.000556	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ADSL—atopic dermatitis	2.18e-05	0.00055	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CCR5—atopic dermatitis	1.93e-05	0.000488	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GLB1—atopic dermatitis	1.82e-05	0.000458	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.74e-05	0.00044	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.74e-05	0.000439	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PPARA—atopic dermatitis	1.72e-05	0.000435	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.58e-05	0.000398	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PPARA—atopic dermatitis	1.55e-05	0.000392	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.4e-05	0.000354	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PPARA—atopic dermatitis	1.35e-05	0.000341	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.34e-05	0.000339	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.32e-05	0.000334	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CD4—atopic dermatitis	1.21e-05	0.000306	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PPARA—atopic dermatitis	1e-05	0.000253	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PPARA—atopic dermatitis	9.79e-06	0.000247	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PPARA—atopic dermatitis	7.38e-06	0.000186	CbGpPWpGaD
Erythromycin—ABCC1—Disease—IL6—atopic dermatitis	6.57e-06	0.000166	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PPARA—atopic dermatitis	5.89e-06	0.000149	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PPARA—atopic dermatitis	4.55e-06	0.000115	CbGpPWpGaD
